Related Experiment Video
Updated: Dec 23, 2025
06:51
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
15.7K
Summary
KTE-X19, a chimeric antigen receptor T-cell therapy, shows significant promise for relapsed/refractory mantle cell lymphoma. This therapy is under FDA priority review, potentially becoming a new standard of care for this rare cancer.
Area of Science:
- Oncology
- Immunotherapy
Background:
- Mantle cell lymphoma (MCL) is a rare, aggressive non-Hodgkin lymphoma.
- Relapsed/refractory MCL has limited treatment options and poor prognosis.
Purpose of the Study:
- To evaluate the efficacy and safety of KTE-X19 in patients with relapsed/refractory MCL.
- To assess the potential of KTE-X19 as a new standard of care.
Main Methods:
- KTE-X19 is an investigational chimeric antigen receptor T-cell (CAR-T) therapy.
- Data from the ZUMA-2 trial were analyzed.
Main Results:
- KTE-X19 demonstrated promising efficacy in the ZUMA-2 trial.
- The therapy is currently under priority review by the FDA.
Conclusions:
- KTE-X19 represents a potential breakthrough in treating relapsed/refractory MCL.
- FDA priority review suggests significant therapeutic potential for this CAR-T therapy.
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
01:21Stem Cell Therapy for Tissue Regeneration
4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K